Works matching AU Popat, Rakesh

Results: 85

Treatment preferences of patients with relapsed or refractory multiple myeloma in the United States, United Kingdom, Italy, Germany, France, and Spain: results from a discrete choice experiment.

Published in:

Frontiers in Medicine, 2023, p. 1, doi. 10.3389/fmed.2023.1271657

By:

Thomas, Caitlin;
Ailawadhi, Sikander;
Popat, Rakesh;
Kleinman, David;
Ross, Melissa M.;
Gorsh, Boris;
Mulnick, Sarah;
O'Neill, Alicia;
Paka, Prani;
Hanna, Maya;
Krucien, Nicolas;
Molinari, Alexa

Publication type:

Article

Functional and psychological impact of minimal residual disease assessment on patients with multiple myeloma.

Published in:

British Journal of Haematology, 2023, v. 202, n. 5, p. e43, doi. 10.1111/bjh.18948

By:

Correia, Nuno;
Dowling, Emma;
Popat, Rakesh;
Rabin, Neil;
Kyriakou, Chara;
Sive, Jonathan;
Yong, Kwee;
Wechalekar, Ashutosh

Publication type:

Article

A UK consensus algorithm for early treatment modification in newly diagnosed systemic light‐chain amyloidosis.

Published in:

British Journal of Haematology, 2022, v. 198, n. 2, p. 328, doi. 10.1111/bjh.18216

By:

Ravichandran, Sriram;
Mahmood, Shameem;
Wisniowski, Brenden;
Sachchithanantham, Sajitha;
Popat, Rakesh;
Lachmann, Helen;
Rabin, Neil;
Ramasamy, Karthik;
Hawkins, Stephen;
Kyriakou, Charalampia;
Gillmore, Julian;
Yong, Kwee;
Hawkins, Philip;
Jackson, Graham;
Pratt, Guy;
D. Wechalekar, Ashutosh

Publication type:

Article

Applying current smouldering myeloma risk models to a UK single‐centre cohort and clinical features at progression.

Published in:

British Journal of Haematology, 2022, v. 196, n. 6, p. e63, doi. 10.1111/bjh.17969

By:

Ainley, Louise;
Camilleri, Marquita;
Chavda, Selina J.;
McMillan, Annabel;
Lee, Lydia;
Popat, Rakesh;
Sillito, Francesca;
Yong, Kwee

Publication type:

Article

Outcomes of relapse in patients with deferred autologous stem cell transplant after achieving at least very good partial response following bortezomib, adriamycin, dexamethasone chemotherapy for newly diagnosed multiple myeloma in the phase II PADIMAC trial

Published in:

British Journal of Haematology, 2022, v. 196, n. 4, p. e33, doi. 10.1111/bjh.17903

By:

Chan, Wei Yee;
Counsell, Nicholas;
de Tute, Ruth;
De‐Silva, Dunnya;
Phillips, Elizabeth H.;
Cavenagh, Jamie;
Adedayo, Toyin;
Braganca, Nivette;
Roddie, Claire;
Streetly, Matthew;
Schey, Stephen;
Koh, Mickey B.C.;
Crowe, Josephine;
Morris, Treen C.;
Cook, Gordon;
Clifton‐Hadley, Laura;
Rabin, Neil;
Owen, Roger G.;
Popat, Rakesh;
Yong, Kwee L.

Publication type:

Article

Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV‐19 COVID‐19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors.

Published in:

British Journal of Haematology, 2022, v. 196, n. 3, p. e21, doi. 10.1111/bjh.17864

By:

Chan, Wei Yee;
Howells, Lara;
Wilson, William;
Sanchez, Emilie;
Ainley, Louise;
Chavda, Selina J.;
Dowling, Emma;
Correia, Nuno;
Lecat, Catherine S. Y.;
McMillan, Annabel;
Wisniowski, Brendan;
Mahmood, Shameem;
Papanikolaou, Xenofon;
Lee, Lydia;
Sive, Jonathan;
Kyriakou, Charalampia;
Wechalekar, Ashutosh;
Popat, Rakesh;
Rabin, Neil;
Nastouli, Eleni

Publication type:

Article

Development of antibody response to SARS‐CoV‐2 following asymptomatic infection in patients with plasma cell disorders on immunomodulatory therapy.

Published in:

British Journal of Haematology, 2021, v. 194, n. 5, p. 857, doi. 10.1111/bjh.17441

By:

Chan, Wei Yee;
Sanchez, Emilie;
Chavda, Selina J.;
Lecat, Catherine S. Y.;
Ainley, Louise;
Xu, Ke;
Wisniowski, Brendan;
Mahmood, Shameem;
Papanikolaou, Xenofon;
Kyriakou, Charalampia;
Sive, Jonathan;
Wechalekar, Ashutosh;
Popat, Rakesh;
Rabin, Neil;
Lee, Lydia;
Nastouli, Eleni;
Yong, Kwee L.

Publication type:

Article

Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study.

Published in:

British Journal of Haematology, 2021, v. 193, n. 4, p. 750, doi. 10.1111/bjh.17377

By:

Camilleri, Marquita;
Cuadrado, Maria;
Phillips, Elizabeth;
Wilson, William;
Jenner, Richard;
Pang, Gavin;
Kamora, Sumaiya;
Streetly, Matthew;
Popat, Rakesh;
Bygrave, Ceri;
Owen, Roger;
Cavenagh, James;
Chapman, Mike;
Sive, Jonathan;
Eccersley, Lydia;
Sheaff, Michael;
Benjamin, Reuben;
Ramasamy, Karthik;
Cook, Gordon;
Virchis, Andres

Publication type:

Article

Using depth of response to stratify patients to front line Autologous Stem Cell Transplant: results of the phase II PADIMAC Myeloma Trial.

Published in:

British Journal of Haematology, 2021, v. 193, n. 3, p. e19, doi. 10.1111/bjh.17391

By:

Popat, Rakesh;
Counsell, Nicholas;
de Tute, Ruth;
De‐Silva, Dunnya;
Phillips, Elizabeth H.;
Cavenagh, Jamie D.;
Adedayo, Toyin;
Braganca, Nivette;
Roddie, Claire;
Streetly, Matthew;
Schey, Steve;
Koh, Mickey B. C.;
Crowe, Josephine;
Morris, Treen C.;
Cook, Gordon;
Smith, Paul;
Clifton‐Hadley, Laura;
Rabin, Neil;
Owen, Roger;
Yong, Kwee

Publication type:

Article

Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction.

Published in:

2017

By:

Latifoltojar, Arash;
Hall-Craggs, Margaret;
Bainbridge, Alan;
Rabin, Neil;
Popat, Rakesh;
Rismani, Ali;
D'Sa, Shirley;
Dikaios, Nikolaos;
Sokolska, Magdalena;
Antonelli, Michela;
Ourselin, Sebastien;
Yong, Kwee;
Taylor, Stuart;
Halligan, Steve;
Punwani, Shonit;
Taylor, Stuart A

Publication type:

journal article

The UK consensus supporting effective introduction of novel treatments for multiple myeloma in the National Health Service.

Published in:

EJHaem, 2024, v. 5, n. 6, p. 1133, doi. 10.1002/jha2.1038

By:

Popat, Rakesh;
Basu, Supratik;
Henshaw, Sarah;
Karunanithi, Kamaraj;
Ramasamy, Karthik;
Singh, Inderjit;
Tailor, Anish;
Walker, Ian;
Warren, Tim;
Ali, Noreen;
Duffield, Charles;
Cook, Gordon

Publication type:

Article

Outcomes of melphalan 140 mg/m<sup>2</sup> followed by autologous stem cell transplantation in multiple myeloma patients with co‐morbidities: Single‐centre experience.

Published in:

EJHaem, 2024, v. 5, n. 5, p. 1102, doi. 10.1002/jha2.977

By:

Melotti, Dario;
Asher, Samir;
Troy‐Barnes, Ethan;
Nesr, George;
Wilson, William;
Camilleri, Marquita;
Popat, Rakesh;
Xu, Ke;
Rabin, Neil;
Sive, Jonathan;
Papanikolaou, Xenofon;
Lee, Lydia;
McMillan, Annabel;
Yong, Kwee;
Kyriakou, Chara

Publication type:

Article

Myeloid neoplasm post cytotoxic treatment in patients with multiple myeloma.

Published in:

EJHaem, 2024, v. 5, n. 5, p. 1089, doi. 10.1002/jha2.1017

By:

Xu, Ke;
Kaffo, Eleanor;
Baker, Robert;
Nacheva, Elisabeth;
McMillan, Annabel;
Lee, Lydia;
Papanikolaou, Xenofon;
Popat, Rakesh;
Sive, Jonathan;
Yong, Kwee;
Rabin, Neil;
Kyriakou, Charalampia;
Gupta, Rajeev

Publication type:

Article

Clinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With Talquetamab.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 10, p. 665, doi. 10.1016/j.clml.2024.05.003

By:

Chari, Ajai;
Krishnan, Amrita;
Rasche, Leo;
Ye, Jing Christine;
Garfall, Alfred;
Popat, Rakesh;
Lipe, Brea;
Qin, Xiang;
Campagna, Michela;
Masterson, Tara;
Tomlinson, Chalmer;
Hilder, Brandi;
Tolbert, Jaszianne;
Renaud, Thomas;
Smit, M. Damiette;
Gray, Kathleen;
Kane, Colleen;
Heuck, Christoph;
Donk, Niels W.C.J. van de

Publication type:

Article

Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma: Results From the Phase II MajesTEC-1 Study.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 3, p. 194, doi. 10.1016/j.clml.2023.11.001

By:

Martin, Thomas G.;
Moreau, Philippe;
Usmani, Saad Z.;
Garfall, Alfred;
Mateos, Maria-Victoria;
San-Miguel, Jesus F.;
Oriol, Albert;
Nooka, Ajay K.;
Rosinol, Laura;
Chari, Ajai;
Karlin, Lionel;
Krishnan, Amrita;
Bahlis, Nizar;
Popat, Rakesh;
Besemer, Britta;
Martfnez-Lopez, Joaquin;
Delforge, Michel;
Trancucci, Danielle;
Pei, Lixia;
Kobos, Rachel

Publication type:

Article

P-219: Relationship between corneal exam findings, best-corrected visual acuity, and ocular symptoms in patients with relapsed or refractory multiple myeloma receiving belantamab mafodotin.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S160, doi. 10.1016/S2152-2650(21)02346-6

By:

Terpos, Evangelos;
Badros, Ashraf Z.;
Popat, Rakesh;
Rodríguez-Otero, Paula;
Farooq, Asim V.;
Jeng, Bennie;
Esposti, Simona Degli;
Lewis, Eric;
Gupta, Ira;
Opalinska, Joanna;
Palumbo, Antonio;
Trudel, Suzanne;
Jadhav, Vinay

Publication type:

Article

P-202: Characterization of ocular adverse events in patients receiving Belantamab Mafadotin for ≥12 months: post-hoc analysis of DREAMM-2 study in relapsed/refractory Multiple Myeloma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S149, doi. 10.1016/S2152-2650(21)02329-6

By:

Lonial, Sagar;
Nooka, Ajay;
Thulasi, Praneetha;
Badros, Ashraf Z.;
Jeng, Bennie;
Callander, Natalie S.;
Sborov, Douglas;
Zaugg, Brian E.;
Popat, Rakesh;
Esposti, Simona Degli;
Baron, January;
Doherty, Allison;
Lewis, Eric;
Opalinska, Joanna;
Prani Paka;
Piontek, Trisha;
Gupta, Ira;
Farooq, Asim V.;
Jakubowiak, Andrzej

Publication type:

Article

P-039: Adaptation of a myeloma minimal residual disease multi-parametric flow assay for real world practice.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S59, doi. 10.1016/S2152-2650(21)02173-X

By:

McMillan, Annabel;
Tran, Thien-an;
Galas-Filipowicz, Daria;
Guo, Yanping;
Camilleri, Marquita;
Xu, Ke;
Lee, Lydia;
Papanikolaou, Xenofon;
Kyriakou, Charalampia;
Rabin, Neil;
Popat, Rakesh;
Yong, Kwee;
Sive, Jonathan

Publication type:

Article

OAB-047: Plasma cell disorder patients are left vulnerable after one dose of the BNT162b2 mRNA or the ChAdOx-nCOV-19 COVID-19 vaccines.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S30, doi. 10.1016/S2152-2650(21)02121-2

By:

Wei Yee Chan;
Howells, Lara;
Wilson, William;
Sanchez, Emilie;
Ainley, Louise;
Chavda, Selina;
Dowling, Emma;
Correia, Nuno;
Lecat, Catherine;
McMillan, Annabel;
Wisniowski, Brendan;
Mahmood, Shameem;
Papanikolaou, Xenofon;
Lee, Lydia;
Sive, Jonathan;
Kyriakou, Charalampia;
Wechalekar, Ashutosh;
Popat, Rakesh;
Rabin, Neil;
Nastouli, Eleni

Publication type:

Article

OAB-013: Iberdomide (IBER) in combination with dexamethasone (DEX) and daratumumab (DARA), bortezomib (BORT), or carfilzomib (CFZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S9, doi. 10.1016/S2152-2650(21)02087-5

By:

Lonial, Sagar;
Richardson, Paul G.;
Popat, Rakesh;
Stadtmauer, Edward A.;
Larsen, Jeremy T.;
Oriol, A.;
Knop, Stefan;
Jagannath, Sundar;
Cook, Gordon;
Badros, Ashraf Z.;
Rodríguez-Otero, Paula;
Siegel, David S.;
Tuong Vi Nguyen;
Micco, Antonia Di;
Amin, Alpesh;
Min Chen;
Kueenburg, Elisabeth;
van de Donk, Niels W.C.J.

Publication type:

Article

OAB-003: CARDAMON:Carfilzomib (K) maintenance following Autologous Stem Cell Transplant (ASCT) or carfilzomib-cyclophosphamide-dexamethasone (KCd) consolidation for newly diagnosed (NDTE) multiple myeloma (MM).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S2, doi. 10.1016/S2152-2650(21)02077-2

By:

Popat, Rakesh;
Wilson, William;
Camilleri, Marquita;
Tute, Ruth De;
Pang, Gavin;
Jenner, Richard;
Dadaga, Tushhar;
Kamora, Sumaiya;
Streetly, Matthew;
Ramasamy, Karthik;
Phillips, Elizabeth;
Chapman, Mike;
Bygrave, Ceri;
Cavenagh, James;
Sive, Jonathan;
Benjamin, Reuben;
Eccersley, Lydia;
Hassan, Sandra;
Willis, Fenella;
Clifton-Hadley, Laura

Publication type:

Article

MM-200: A Qualitative Study of Patients' Preferences for the Treatment of Relapsed or Refractory Multiple Myeloma (RRMM) in the United States, United Kingdom, France, and Germany.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S428, doi. 10.1016/S2152-2650(21)01955-8

By:

Thomas, Caitlin;
Gelhorn, Heather;
Mulnick, Sarah;
Popat, Rakesh;
Ailawadhi, Sikander;
Kleinman, David;
McDermott, Eleanor;
Gorsh, Boris;
Perera, Sue;
Eliason, Laurie;
Sapra, Sandhya;
Sansbury, Leah;
O'Neill, Alicia;
Paka, Prani;
Galinsky, Jayne;
Tolley, Julia;
Ross, Melissa

Publication type:

Article

MM-103: Relationship Between Corneal Exam Findings, Best-Corrected Visual Acuity (BCVA), and Ocular Symptoms in Patients with Relapsed or Refractory Multiple Myeloma (RRMM) Receiving Belantamab Mafodotin (GSK2857916; Belamaf).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S421, doi. 10.1016/S2152-2650(21)01944-3

By:

Terpos, Evangelos;
Badros, Ashraf;
Popat, Rakesh;
Rodriguez-Otero, Paula;
Farooq, Asim;
Jeng, Bennie;
Esposti, Simona Degli;
Lewis, Eric;
Gupta, Ira;
Opalinska, Joanna;
Palumbo, Antonio;
Trudel, Suzanne

Publication type:

Article

MM-078: Characterization of Ocular Adverse Events in Patients Receiving Belantamab Mafodotin (Belamaf) for ≥12 Months: Post Hoc Analysis of DREAMM-2 Study in Relapsed/Refractory Multiple Myeloma (RRMM).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S419, doi. 10.1016/S2152-2650(21)01940-6

By:

Lonial, Sagar;
Nooka, Ajay K.;
Thulasi, Praneetha;
Badros, Ashraf Z.;
Jeng, Bennie H.;
Callander, Natalie S.;
Sborov, Douglas;
Zaugg, Brian E.;
Popat, Rakesh;
Esposti, Simona Degli;
Baron, January;
Doherty, Allison;
Lewis, Eric;
Opalinska, Joanna;
Paka, Prani;
Piontek, Trisha;
Gupta, Ira;
Farooq, Asim V.;
Jakubowiak, Andrzej

Publication type:

Article

Poster: MM-200: A Qualitative Study of Patients' Preferences for the Treatment of Relapsed or Refractory Multiple Myeloma (RRMM) in the United States, United Kingdom, France, and Germany.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S255, doi. 10.1016/S2152-2650(21)01598-6

By:

Thomas, Caitlin;
Gelhorn, Heather;
Mulnick, Sarah;
Popat, Rakesh;
Ailawadhi, Sikander;
Kleinman, David;
McDermott, Eleanor;
Gorsh, Boris;
Perera, Sue;
Eliason, Laurie;
Sapra, Sandhya;
Sansbury, Leah;
O'Neill, Alicia;
Paka, Prani;
Galinsky, Jayne;
Tolley, Julia;
Ross, Melissa

Publication type:

Article

Poster: MM-103: Relationship Between Corneal Exam Findings, Best-Corrected Visual Acuity (BCVA), and Ocular Symptoms in Patients with Relapsed or Refractory Multiple Myeloma (RRMM) Receiving Belantamab Mafodotin (GSK2857916; Belamaf).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S251, doi. 10.1016/S2152-2650(21)01577-9

By:

Terpos, Evangelos;
Badros, Ashraf;
Popat, Rakesh;
Rodriguez-Otero, Paula;
Farooq, Asim;
Jeng, Bennie;
Esposti, Simona Degli;
Lewis, Eric;
Gupta, Ira;
Opalinska, Joanna;
Palumbo, Antonio;
Trudel, Suzanne

Publication type:

Article

Poster: MM-078: Characterization of Ocular Adverse Events in Patients Receiving Belantamab Mafodotin (Belamaf) for ≥ 12 Months: Post Hoc Analysis of DREAMM-2 Study in Relapsed/Refractory Multiple Myeloma (RRMM).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S251, doi. 10.1016/S2152-2650(21)01576-7

By:

Lonial, Sagar;
Nooka, Ajay K.;
Thulasi, Praneetha;
Badros, Ashraf Z.;
Jeng, Bennie H.;
Callander, Natalie S.;
Sborov, Douglas;
Zaugg, Brian E.;
Popat, Rakesh;
Esposti, Simona Degli;
Baron, January;
Doherty, Allison;
Lewis, Eric;
Opalinska, Joanna;
Paka, Prani;
Piontek, Trisha;
Gupta, Ira;
Farooq, Asim V.;
Jakubowiak, Andrzej

Publication type:

Article

Ixazomib, lenalidomide and dexamethasone in relapsed AL amyloidosis – a first report.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e309, doi. 10.1016/j.clml.2019.09.508

By:

Cohen, Oliver Charles;
Sharpley, Faye;
Gillmore, Julian;
Lachmann, Helen;
Sachchithanantham, Sajitha;
Mahmood, Shameem;
Quarta, Cristina;
Fontana, Marianna;
Whelan, Carol;
Martinez-Naharro, Ana;
Kyriakou, Charalampia;
Rabin, Neil;
Popat, Rakesh;
Yong, Kwee;
Cheesman, Simon;
Shah, Raakhee;
Hawkins, Philip;
Wechalekar, Ashutosh

Publication type:

Article

Outcomes of newly diagnosed multiple myeloma with deferred ASCT after achieving ≥VGPR following PAD induction in the Phase 2 PADIMAC study.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e288, doi. 10.1016/j.clml.2019.09.475

By:

Chan, Wei Yee;
Counsell, Nicholas;
Popat, Rakesh;
De Tute, Ruth;
De-silva, Dunnya;
Phillips, Elizabeth;
Cavenagh, Jamie;
Adedayo, Toyin;
Braganca, Nivette;
Roddie, Claire;
Streetly, Matthew;
Schey, Steve;
Koh, Mickey;
Crowe, Josephine;
Quinn, Michael;
Morris, Curly;
D'Sa, Shirley;
Virchis, Andres;
Cook, Gordon;
Crawley, Charles

Publication type:

Article

Real World Use of Ixazomib With Lenalidomide and Dexamethasone for Patients With Relapsed Multiple Myeloma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e264, doi. 10.1016/j.clml.2019.09.436

By:

Lawson, Gabrielle;
Ziff, Monica;
De-silva, Dunnya;
Cheesman, Simon;
Kyriakou, Charalampia;
Mehta, Atul;
Mahmood, Shameem;
Papanikolaou, Xenofon;
Rabin, Neil;
Sachchithanantham, Sajitha;
Sive, Jonathan;
Wechalekar, Ashutosh;
Yong, Kwee;
Popat, Rakesh

Publication type:

Article

Comparison of PET Reconstruction Algorithms on Assessment and Quantification of FDG-PETCT Findings in Patients with Multiple Myeloma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e171, doi. 10.1016/j.clml.2019.09.286

By:

Arulogun, Suzanne;
Riaz, Saima;
Rabin, Neil;
Smith, April-Louise;
Wan, Simon;
Yong, Kwee;
Kyriakou, Charalampia;
Wechalekar, Ashutosh;
Popat, Rakesh;
Sive, Jonathan;
Papanikolaou, Xenofon;
Mahmood, Shameem;
Sachchithanantham, Sajitha;
Bomanji, Jamshed

Publication type:

Article

Durability of Response and Characterisation of Corneal events with Extended follow-up after Belantamab Mafodotin monotherapy for patients with relapsed/refractory Multiple Myeloma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e150, doi. 10.1016/j.clml.2019.09.250

By:

Popat, Rakesh;
Warcel, Dana;
O'Nions, Jenny;
Cowley, Anna;
Smith, Sasha;
Yong, Kwee;
Esposti, Simona Degli

Publication type:

Article

A Phase 1b/2a Study of the CELMoD Iberdomide (CC-220) in Combination With Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e52, doi. 10.1016/j.clml.2019.09.080

By:

Lonial, Sagar;
Van de Donk, Niels;
Popat, Rakesh;
Zonder, Jeffrey A.;
Minnema, Monique;
Larsen, Jeremy T.;
Nguyen, Tuong Vi;
Chen, Min S.;
Bensmaine, Amine;
Peluso, Teresa;
Sonneveld, Pieter

Publication type:

Article

A Phase 3 Study of Venetoclax or Placebo in Combination with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e31, doi. 10.1016/j.clml.2019.09.046

By:

Kumar, Shaji;
Harrison, Simon J.;
Cavo, Michele;
Rubia, Javier DE.LA.;
Popat, Rakesh;
Gasparetto, Cristina J.;
Hungria, Vania;
Salwender, Hans J.;
Suzuki, Kenshi;
Kim, Inho;
Punnoose, Elizabeth;
Hong, Wan-Jen;
Freise, Kevin J.;
Sood, Anjla;
Jalaluddin, Muhammad;
Ross, Jeremy;
Ward, James E.;
Maciag, Paulo;
Moreau, Philippe

Publication type:

Article

Optimal Management of Histone Deacetylase Inhibitor-Related Adverse Events in Patients With Multiple Myeloma: A Focus on Panobinostat.

Published in:

2018

By:

Cavenagh, Jamie D.;
Popat, Rakesh

Publication type:

journal article

Real World Data of the Impact of first cycle Daratumumab on Multiple Myeloma and Amyloidosis Services.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e157, doi. 10.1016/j.clml.2017.03.284

By:

Pandit, Devanshi;
Dowling, Emma;
Achhala, Sufyan;
Rabin, Neil;
Kyriakou, Charalampia;
Wechalekar, Ashutosh;
Mackinnon, Stephen;
Yong, Kwee;
Popat, Rakesh

Publication type:

Article

Correction to: Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody–Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study.

Published in:

2020

By:

Farooq, Asim V.;
Degli Esposti, Simona;
Popat, Rakesh;
Thulasi, Praneetha;
Lonial, Sagar;
Nooka, Ajay K.;
Jakubowiak, Andrzej;
Sborov, Douglas;
Zaugg, Brian E.;
Badros, Ashraf Z.;
Jeng, Bennie H.;
Callander, Natalie S.;
Opalinska, Joanna;
Baron, January;
Piontek, Trisha;
Byrne, Julie;
Gupta, Ira;
Colby, Kathryn

Publication type:

Correction Notice

Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody–Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study.

Published in:

Ophthalmology & Therapy, 2020, v. 9, n. 4, p. 889, doi. 10.1007/s40123-020-00280-8

By:

Farooq, Asim V.;
Degli Esposti, Simona;
Popat, Rakesh;
Thulasi, Praneetha;
Lonial, Sagar;
Nooka, Ajay K.;
Jakubowiak, Andrzej;
Sborov, Douglas;
Zaugg, Brian E.;
Badros, Ashraf Z.;
Jeng, Bennie H.;
Callander, Natalie S.;
Opalinska, Joanna;
Baron, January;
Piontek, Trisha;
Byrne, Julie;
Gupta, Ira;
Colby, Kathryn

Publication type:

Article

Rapid response to single agent daratumumab is associated with improved progression-free survival in relapsed/refractory AL amyloidosis.

Published in:

Amyloid, 2020, v. 27, n. 3, p. 200, doi. 10.1080/13506129.2020.1765768

By:

Cohen, Oliver C.;
Brodermann, Maximillian H.;
Blakeney, Iona J.;
Mahmood, Shameem;
Sachchithanantham, Sajitha;
Ravichandran, Sriram;
Law, Steven;
Lachmann, Helen J.;
Whelan, Carol J.;
Popat, Rakesh;
Rabin, Neil;
Yong, Kwee;
Kyriakou, Charalampia;
Shah, Raakhee;
Cheesman, Simon;
Worthington, Sarah;
Hawkins, Philip;
Gillmore, Julian D.;
Wechalekar, Ashutosh D.

Publication type:

Article

Antibody-drug conjugates for multiple myeloma.

Published in:

Expert Opinion on Biological Therapy, 2021, v. 21, n. 7, p. 889, doi. 10.1080/14712598.2020.1802422

By:

McMillan, Annabel;
Warcel, Dana;
Popat, Rakesh

Publication type:

Article

Single‐agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM‐2 trial.

Published in:

Cancer (0008543X), 2023, v. 129, n. 23, p. 3746, doi. 10.1002/cncr.34987

By:

Nooka, Ajay K.;
Cohen, Adam D.;
Lee, Hans C.;
Badros, Ashraf;
Suvannasankha, Attaya;
Callander, Natalie;
Abdallah, Al‐Ola;
Trudel, Suzanne;
Chari, Ajai;
Libby, Edward N.;
Chaudhry, Maria;
Hultcrantz, Malin;
Kortüm, K. Martin;
Popat, Rakesh;
Sborov, Douglas;
Hakim, Shawn;
Lewis, Eric;
Gorsh, Boris;
Bhushan, Bharat;
McKeown, Astrid

Publication type:

Article

Perspectives of Healthcare Providers and Patients with Relapsed/Refractory Multiple Myeloma on Treatment Priorities and Novel Therapies.

Published in:

Patient Preference & Adherence, 2025, v. 18, p. 1089, doi. 10.2147/PPA.S496106

By:

Ailawadhi, Sikander;
Biru, Yelak;
Clavreul, Solène;
Miguel, Maite San;
Cormier, Nicolas;
Efebera, Yvonne;
Merz, Maximilian;
Sato, Anna;
Zeanah, Cathy;
Watkins, Jack L;
Farrell, James;
Goldman, Erinn Hoag;
Popat, Rakesh

Publication type:

Article

DT‐PACE/ESHAP chemotherapy regimens as salvage therapy for multiple myeloma prior to autologous stem cell transplantation.

Published in:

British Journal of Haematology, 2021, v. 192, n. 3, p. e73, doi. 10.1111/bjh.17248

By:

Ainley, Louise;
Chavda, Selina J.;
Counsell, Nicholas;
Cheesman, Simon;
Newrick, Fiona;
Horder, Jackie;
Kyriakou, Charalampia;
Papanikolaou, Xenofon;
Sive, Jonathan;
Lee, Lydia;
Wechalekar, Ashutosh;
Mehta, Atul;
Popat, Rakesh;
Rabin, Neil;
Yong, Kwee

Publication type:

Article

COVID‐19 and myeloma clinical research – experience from the CARDAMON clinical trial.

Published in:

British Journal of Haematology, 2021, v. 192, n. 1, p. e14, doi. 10.1111/bjh.17168

By:

Camilleri, Marquita;
Sive, Jonathan;
Wilson, William;
Pang, Gavin;
Jenner, Richard;
Phillips, Elizabeth;
Popat, Rakesh;
Ramasamy, Karthik;
Bygrave, Ceri;
Dadaga, Tushhar;
Streetly, Matthew;
Cavenagh, James;
Chapman, Mike;
Barrington, Sally;
Pike, Lucy;
Owen, Roger;
Clifton‐Hadley, Laura;
Yong, Kwee

Publication type:

Article

A real‐world study of panobinostat, weekly bortezomib and dexamethasone in a very heavily pretreated population of multiple‐myeloma patients.

Published in:

British Journal of Haematology, 2020, v. 191, n. 5, p. 927, doi. 10.1111/bjh.17076

By:

Bird, Sarah;
Pawlyn, Charlotte;
Nallamilli, Susanna;
Sriskandarajah, Priya;
Kaiser, Martin;
Yong, Kwee;
Popat, Rakesh;
Rabin, Neil;
Boyd, Kevin

Publication type:

Article

Association of hypertension and cardiac events in patients with multiple myeloma receiving carfilzomib: practical management recommendations.

Published in:

British Journal of Haematology, 2020, v. 190, n. 5, p. e312, doi. 10.1111/bjh.16889

By:

Chavda, Selina J.;
Pocock, Rachael;
Cheesman, Simon;
Lee, Kyung‐Min;
Dowling, Emma;
Marks, Daniel J. B.;
Kyriakou, Charalampia;
Lee, Lydia;
Sive, Jonathan;
Wechalekar, Ashutosh;
Rabin, Neil;
Yong, Kwee;
Popat, Rakesh

Publication type:

Article

Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID‐19 disease) in patients with multiple myeloma receiving systemic anti‐cancer therapy.

Published in:

British Journal of Haematology, 2020, v. 190, n. 2, p. e83, doi. 10.1111/bjh.16874

By:

Cook, Gordon;
John Ashcroft, A;
Pratt, Guy;
Popat, Rakesh;
Ramasamy, Karthik;
Kaiser, Martin;
Jenner, Matthew;
Henshaw, Sarah;
Hall, Rachel;
Sive, Jonathan;
Stern, Simon;
Streetly, Matthew;
Bygrave, Ceri;
Soutar, Richard;
Rabin, Neil;
Jackson, Graham H

Publication type:

Article

Use of ixazomib, lenalidomide and dexamethasone in patients with relapsed amyloid light‐chain amyloidosis.

Published in:

British Journal of Haematology, 2020, v. 189, n. 4, p. 643, doi. 10.1111/bjh.16401

By:

Cohen, Oliver C.;
Sharpley, Faye;
Gillmore, Julian D.;
Lachmann, Helen J.;
Sachchithanantham, Sajitha;
Mahmood, Shameem;
Fontana, Marianna;
Whelan, Carol J.;
Martinez‐Naharro, Ana;
Kyriakou, Charalampia;
Rabin, Neil;
Popat, Rakesh;
Yong, Kwee;
Cheesman, Simon;
Shah, Raakhee;
Hawkins, Philip N.;
Wechalekar, Ashutosh D.

Publication type:

Article

Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy.

Published in:

British Journal of Haematology, 2019, v. 187, n. 5, p. 638, doi. 10.1111/bjh.16122

By:

Manwani, Richa;
Mahmood, Shameem;
Sachchithanantham, Sajitha;
Lachmann, Helen J.;
Gillmore, Julian D.;
Yong, Kwee;
Rabin, Neil;
Popat, Rakesh;
Kyriakou, Charalampia;
Worthington, Sarah;
Sharpley, Faye;
Smith, Mark;
Shah, Raakhee;
Cheesman, Simon;
Hawkins, Philip N.;
Wechalekar, Ashutosh D.

Publication type:

Article

Clinical benefit of depth of response for relapsed/refractory multiple myeloma patients treated on clinical trials: retrospective analysis from two tertiary centres.

Published in:

British Journal of Haematology, 2019, v. 186, n. 1, p. 162, doi. 10.1111/bjh.15743

By:

Chan, Esther H. L.;
De‐Silva, Dunnya;
Lin, Adeline H. F.;
Rabin, Neil;
Wechalekar, Ashutosh;
Popat, Rakesh;
Chng, Wee Joo;
Yong, Kwee L.

Publication type:

Article